Category health

Delhi, 3rd June 2024: Marking the occasion of World No Tobacco Day, HCMCT Manipal Hospital Dwarka, New Delhi conducted comprehensive pulmonology tests in various sectors of Dwarka. This activity aimed to raise awareness about the dangers of smoking and how it impacts the lungs and overall health. During this activity, more than 200 individuals aged between 30 and 60 participated. Experts from HCMCT Manipal Hospital used spirometers to screen the lung capacity and respiratory systems of the participants.

During this activity, Dr. Puneet Khanna, HOD, Pulmonology & Respiratory Medicine, HCMCT Manipal Hospital Dwarka, New Delhi addressed the participants, “This was a Dumdaar challenge for the common citizens of Delhi. The whole exercise aims to create awareness about lung health on World No Tobacco Day because we have seen that because of tobacco addiction, more and more youngsters are getting affected, and their lungs are getting damaged because of tobacco addiction. In this initiative, we are urging the citizens to take care of their lungs, do this challenge, and have knowledge about their lung capacity and lung functions.”

Chennai, 1st June 2024 : MGM Cancer Institute, a leading cancer care facility in Chennai, has announced the successful completion of a critical surgical procedure to remove a 30cm cancerous tumor from a 30-year-old patient from West Bengal. The surgery was performed by the RECNAC team at MGM Cancer Institute, including Dr. Balaji Ramani, Dr. Sivakumar Mahalingam, Dr. Sivaram Ganeshmoni, and Dr. Dhanasekar Padmanabhan, Surgical Oncologists at the institute.

The patient was diagnosed with Ewing Sarcoma, a rare cancer that typically affects the bones and surrounding soft tissues, most commonly found in children and young adults. Previously, the patient had undergone two tumor removal surgeries and two cycles of chemotherapy at a private hospital in Kolkata, but the tumor recurred, growing into a massive fungating mass that compressed his shoulder and arm.

Facing a recommendation for tumor excision and left limb amputation from his previous doctors, Mr. Subhan Ray (Named Changed) sought a second opinion at MGM Cancer Institute as a last resort. The RECNAC team at MGM Cancer Institute examined the patient, analyzed the tumor using complex 3D reconstruction imaging and then decided to undertake the challenging task of removing the tumor without causing harm to the arm. Along with the patient’s weakened condition and low hemoglobin levels, further evaluation revealed that the tumor was very close to essential vessels and nerves offering only a slim chance to save the limb.

With the assistance of Dr. Sabari Girish, Lead Plastic Surgeon at MGM Cancer Institute, the RECNAC team successfully resected the tumor completely, preserving the patient’s left arm using flap reconstruction technique.

Dr. Balaji Ramani, Senior Consultant in Surgical Oncology at MGM Cancer Institute, commented on the complexity of the surgery: “This is a rare case. Despite undergoing two previous tumor removal surgeries and chemotherapy, the tumor continued to grow, bleed, and became a large fungating mass. The patient could no longer undergo chemotherapy sessions. Believing limb removal was the only option, the patient and his family had lost hope. We advised one last surgery to remove the tumor before it could affect the bones. We meticulously planned the surgery using advanced 3D imaging techniques, and were able to completely remove the tumor without amputating the limb.”

Expressing his gratitude, the patient said, “I am incredibly thankful to the entire team at MGM Cancer Institute. Their expertise and compassion have given me a new lease on life. I am optimistic about my recovery and look forward to resuming my usual activities.”

This case underscores the importance of early detection and the availability of advanced medical treatment options for rare cancers like Ewing Sarcoma. MGM Cancer Institute, part of MGM Healthcare, remains committed to advancing cancer treatment through innovative approaches and a patient-centered focus.

31st May 2024, Mumbai: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Sacubitril and Valsartan Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Entresto Tablets, 24 mg/26 mg, 49 mg/51 mg, and 97 mg/103 mg, of Novartis Pharmaceuticals Corporation (Novartis).

Sacubitril and Valsartan Tablets are indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. It is also indicated for the treatment of symptomatic heart failure with systemic left ventricular systolic dysfunction in pediatric patients aged one year and older.

Sacubitril and Valsartan Tablets have an estimated market size of US$ 5.3 billion for twelve months ending March 2024 according to IQVIA.

Alembic has a cumulative total of 202 ANDA approvals (174 final approvals and 28 tentative approvals) from USFDA.

ByDr. Priyanka Kuri, Consultant – Dermatology, Aster Whitefield Hospital, Bengaluru

Do you think that the number of allergies to beauty products is high? In case you have ever noticed a rash, itchiness, or redness after using some beauty product, you may be dealing with a cosmetic allergy. The following are how these allergic reactions can be identified, treated, and prevented.

1. Understanding Cosmetic Allergy

Cosmetic allergy is when your immune system responds badly to ingredients present in cosmetics such as makeup, lotions, shampoos, and perfumes among other beauty products. Mistakenly considering one of the cosmetic components to be harmful, triggers an allergic response by your immune system. The reaction’s intensity could range from mild to severe.

2. Common Symptoms

Recognizing the symptoms of a cosmetic allergy is crucial for early intervention. Here’s what to look out for:

• Redness and Rash: Inflamed, red skin or a rash where the product was applied.
• Itching: Intense itching at the site of the application.
• Swelling: Mild to severe swelling in the affected area.
• Blisters or Hives: Raised, red, itchy bumps or blisters.
• Dry, Scaly Skin: Persistent dryness and scaling, especially with repeated exposure.
• Burning or Stinging: A burning or stinging sensation on the skin

3. Top Allergens in Cosmetics

Certain ingredients are more likely to cause allergic reactions. Here are the common culprits:

• Fragrances: Both synthetic and natural fragrances can be allergenic.
• Preservatives: Chemicals like parabens, formaldehyde releasers (e.g., quaternium-15), and isothiazolinones.
• Dyes and Colorants: Synthetic and natural dyes can trigger allergies.
• Metals: Ingredients like nickel in some cosmetics can cause reactions.
• Botanical Extracts: Natural components like essential oils and plant extracts.

4. Diagnosis: How to Confirm a Cosmetic Allergy

If you suspect you have a cosmetic allergy, proper diagnosis is essential:

• Patch Testing: A dermatologist applies small amounts of potential allergens to your skin and monitors for reactions.
• History and Examination: A detailed medical history and skin examination can help identify the offending product.

5. Effective Treatments

Once a cosmetic allergy is confirmed, the primary goal is to relieve symptoms and prevent further reactions:

• Avoidance: Stop using the product causing the reaction.
• Topical Corticosteroids: These creams help reduce inflammation and itching.
• Antihistamines: Oral or topical antihistamines can alleviate symptoms.
• Moisturizers: Hypoallergenic moisturizers soothe and repair the skin barrier.

6. Preventing Cosmetic Allergies

Prevention is better than cure, especially with cosmetic allergies:

• Read Labels: Carefully check ingredient lists and avoid known allergens.
• Patch Test New Products: Apply a small amount of new products to a discrete skin area to test for reactions.
• Choose Hypoallergenic Products: Opt for products labeled as hypoallergenic, fragrance-free, and preservative-free.

7. Consult a Dermatologist

In case adverse reactions persist or if there is any doubt that they are serious it is recommended that patients see a dermatologist. They will prescribe individual advice and treatment methods for managing their allergy effectively.

Although it can be very bothersome having cosmetic allergies knowing what the symptoms are; causes and treatment options can help you control and prevent reactions. Always watch out on what you use on your skin and seek professional advice whenever necessary on matters pertaining to allergic probability.

Guwahati: Renowned neurosurgeon Dr. Ashish Gupta, Senior Director of Neuro Surgery & Spine Surgery, and his medical team at Max Super Speciality Hospital, Patparganj, Delhi, successfully performed a complex minimal invasive spine surgery on Mr. Raben, a 55-year-old male patient from Guwahati. Mr. Raben was admitted with severe neck pain and radicular pain extending into his left upper limb and weakness of hand significantly affecting his quality of life.

Upon admission, Mr. Raben underwent a comprehensive MRI scan of his cervical spine, which revealed several critical issues at the C6-C7 level-Posterior Intervertebral Disc (PIVD), where the disc situated between the sixth and seventh cervical vertebrae had displaced backward. In Mr. Raben’s case, the stenosis at the C6-C7 level was causing compression of the nerve roots exiting at C6 and C7.

Additionally, he exhibited considerable weakness in his right upper limb, indicating that the nerve compression was also affecting his motor functions. This combination of severe pain, nerve compression, and motor weakness necessitated immediate surgical intervention to prevent further deterioration of his condition and to alleviate his symptoms.

The surgical procedure, led by Dr. Ashish Gupta, was immediately executed. This complex operation involved a microdiscectomy (removal of the herniated disc), decompression (relieving pressure on the nerves), neurolysis (freeing the nerves from surrounding tissue), and spinal fusion (using an implant to stabilize the spine). The successful execution of this surgery has resulted in a significant improvement in Mr. Raben’s condition, leading to his early discharge and full recovery.

Mr. Raben was discharged following the successful operation and has made a full recovery. Dr. Gupta expressed satisfaction with the outcome and commended his team for their exceptional performance and dedication to patient care.

“Ensuring the best possible outcomes for our patients is our top priority. Mr. Raben’s case was particularly challenging, but our team’s expertise and the advanced surgical techniques we employed have led to a positive result. We wish Mr. Raben a swift and complete recovery,” said Dr. Ashish Gupta.

In an era where healthcare accessibility and affordability remain critical challenges, Clinics on Cloud emerges as a beacon of innovation and hope. This pioneering health tech company has taken significant strides to bridge the gap in healthcare services through its revolutionary HealthATM platform, transforming the way communities access essential medical services.

Clinics on Cloud stands at the forefront of the health tech industry, driving forward with its commitment to address global healthcare challenges. Their flagship platform, HealthATM, seamlessly integrates basic health checkups and consultations, offering individuals a convenient and efficient way to access high-quality medical care.

Vision and Mission:

Guided by the vision of “HEALTH FOR ALL,” Clinics on Cloud is dedicated to making preventive diagnostics accessible to everyone. Their mission centers on alleviating the burden of illness and healthcare costs globally by providing affordable and instant health checkups through HealthATM. With a vision of placing one health kiosk every 2 kilometres, Clinics on Cloud aims to ensure healthcare is within everyone’s reach.

Key Initiatives:

HealthATM Platform: The cornerstone of Clinics on Cloud‘s innovation, the HealthATM platform, harnesses cutting-edge technology to deliver essential health services to underserved communities. With over 2,500 HealthATMs strategically installed across India, Clinics on Cloud is expanding the reach of preventive healthcare, improving health outcomes for countless individuals. Each HealthATM can check over 60 health parameters in less than 10 minutes, ensuring quick and comprehensive health assessments.

Telemedicine: Clinics on Cloud’s telemedicine feature brings doctors to patients’ screens, providing remote consultations with access to all necessary health reports. This ensures timely medical advice and reduces the need for physical visits, especially in remote areas.

Digital Reports: The platform generates digital reports, allowing patients to review their health records with a click, facilitating better follow-up and continuity of care.

Partnerships: Clinics on Cloud has established strategic partnerships with Public Sector Undertakings and government projects, enhancing the accessibility of their services. By collaborating with these initiatives, Clinics on Cloud is bringing quality medical services closer to people, addressing healthcare disparities in numerous communities.

Impact and Reach:

Since its inception in 2017, Clinics on Cloud has made remarkable progress in the healthcare sector. With operations spanning over 200 cities and a robust presence across India, the company has positively impacted millions of lives. By providing access to essential health checkups and telemedicine facilities, Clinics on Cloud is playing a pivotal role in transforming healthcare accessibility. The company’s focus on prevention over cure ensures that communities stay healthier and reduce the burden of chronic illnesses.

In summary, Clinics on Cloud‘s innovative HealthATM platform is not just a technological marvel but a significant leap towards equitable healthcare. Through their unwavering commitment to “HEALTH FOR ALL,” Clinics on Cloud is making a profound difference in the lives of individuals and communities, one HealthATM at a time.

To learn more about Clinics on Cloud and their groundbreaking initiatives, visit [Clinics on Cloud](https://clinicsoncloud.com).

By Dr. Alekhya Sunkarneni, Consultant Gynaecologist and Obstetrician Ankura Hospital for Women and Children L.B. Nagar Unit

In the landscape of women’s health in India, regular gynaecological check-ups emerge as a critical component for holistic well-being. These routine examinations serve as a cornerstone for early detection of health issues, preventive care, and empowerment of women to prioritize their health needs. Understanding the significance of these check-ups is paramount in fostering a culture of proactive healthcare among women across the nation.

In India, gynaecological check-ups are recommended for women starting from adolescence and continuing throughout their reproductive years and beyond. These examinations encompass a comprehensive evaluation of reproductive health, screenings for common gynaecological conditions, and discussions on family planning, menstrual health, and sexual wellness.

Early detection of gynaecological cancers is one of the primary benefits of regular gynaecological check-ups. In India, cervical cancer ranks as the second most common cancer among women, with an estimated 97,000 new cases diagnosed annually. However, with widespread screening programs and initiatives promoting cervical cancer awareness, there has been a concerted effort to improve early detection and reduce mortality rates.

Furthermore, gynaecological check-ups play a pivotal role in addressing sexual and reproductive health concerns in India. With a significant burden of sexually transmitted infections (STIs) and reproductive tract infections (RTIs) in the country, regular screenings during gynaecological exams facilitate early diagnosis and treatment, thereby mitigating the risk of complications and transmission.

Education and preventive care are also integral aspects of gynaecological check-ups in the Indian context. Healthcare providers offer guidance on topics such as menstrual hygiene, contraception, prenatal care, and menopause management, tailored to the cultural and socio-economic backgrounds of women. Additionally, discussions on lifestyle modifications, including nutrition, physical activity, and tobacco cessation, contribute to promoting overall health and well-being.

Despite the importance of regular gynaecological check-ups, access to healthcare remains a challenge for many women in India. Socioeconomic factors, cultural barriers, and geographic disparities often hinder women from seeking timely medical care. Addressing these barriers through increased awareness, community outreach programs, and improved healthcare infrastructure is crucial in ensuring equitable access to gynaecological services for all women across the country.

In conclusion, regular gynaecological check-ups are indispensable for promoting women’s health and preventing gynaecological conditions in the Indian context. By prioritizing these examinations and fostering a supportive healthcare environment, women can take proactive steps towards safeguarding their health and well-being. Investing in preventive care and early intervention today can pave the way for healthier and empowered women tomorrow.

278th May 2024: OET, a leading English language test provider, has launched a revitalized brand and a comprehensive suite of new brand creatives. This initiative aims to better meet the dynamic needs of healthcare professionals globally, underscoring OET’s commitment to supporting nurses, doctors, and healthcare workers throughout their careers, and simplifying their journey towards global professional success.

For over a decade, the OET test has been at the forefront of English language testing for healthcare. The refreshed brand builds on this legacy, enhancing and synthesizing its offering to outpace competitors in the healthcare sector and solidify its position as a market leader.

The rebrand includes a new creative identity, an updated website, and a brand film directed by Dentsu Creative. The film tells the story of a Kerala nurse and a successful OET Test candidate, Revathy Subhash. It recounts Revathy’s journey from India to the UK, her childhood aspirations to work overseas, and how OET unlocked her dream of living in England. The film illustrates how OET serves as a bridge for healthcare professionals to achieve their global ambitions.

Rebranding film link – https://oet.com/from-here-anywhere

Revathy Subhash and her husband, who met in nursing school, shared a dream of working in Europe. They faced a significant hurdle: their proficiency in English. Recognizing the importance of language skills for their migration journey, Revathy and her husband turned to OET for assistance.

“OET provided me the resources, online classes, practice tests, and follow-ups I needed. With OET, I knew I was on the right track. We received the support to elevate our language skills, so we could live the life we dreamed of in the UK,” shared Revathy Subhash.

Marco Delgado, OET’s Chief Experience Officer, commented on the new brand positioning, saying, “The new brand unveiled today represents OET’s evolution to becoming the leading partner in empowering healthcare professionals with the knowledge, skills, and support they need to excel in their profession, whether domestically or overseas. This new brand platform and campaign allow us to cultivate a nurturing community and environment for our healthcare professionals around the world, built around our market-leading OET test. From when they begin preparing to take the OET test, to finding the first role in their dream healthcare career, OET will support them every step of the way.”

Executive Creative Director of Dentsu Creative, Sarah McGregor said the brand film embodies OET’s customer journey simply, yet effectively.

“In a market that’s often focused on numbers, test scores, and function-first, OET’s new brand campaign puts the candidate first. OET is not a transactional assessment, but rather an accelerant towards a goal – bridging healthcare professions with their dream across the world.”

The new OET brand features an enhanced suite of products, prominently showcased on an intuitive new website, ensuring easier access to resources at all career stages. The brand extensions include:

OET Test

Created by professional language researchers, the OET test is the preferred English proficiency language test for healthcare professionals globally.

Accepted by regulators and healthcare employers globally, the OET test draws upon real-life healthcare scenarios to prepare test takers for real workplace scenarios, encompassing reading, writing, listening, and speaking skills.

OET Ready

OET Ready is a comprehensive exam preparation offering.
The materials include practice tests, study guides and expert guidance, allowing test takers to boost their confidence while also achieving their best OET Test scores.

OET Career

OET Career provides healthcare professionals with employment resources like resume tips, career advice and destination guides, helping them find the best pathway to their dream destination.

OET Access

Geared towards organizations that use the OET test, OET Access includes a range of tailored products for employers, government, and healthcare regulators.

OET Access offers simplified results verification, and versatile solutions to support health institutions, empowering organizations to recognize English proficiency.

The brand campaign, launching on 27 May, will be promoted across digital, YouTube, and social media channels globally. These products are designed to support candidates beyond language testing, providing test-takers with employment opportunities, better test results, and support in moving overseas to achieve their career and lifestyle dreams.

The top 10 countries in which OET delivers testing include India, Saudi Arabia, the UK, the United Arab Emirates, Pakistan, the USA, the Philippines, Kuwait, New Zealand, and Zimbabwe.

OET is a joint venture between Cambridge English (Aus) and Box Hill Institute.

The full OET product suite can be accessed through oet.com

Hyderabad, 28th May 2024: India, home to over 1.3 billion people, faces a severe shortage of blood stem cell donors. With only 0.09% of the population registered as donors, the need for more people to join the stem cell registry is the need of the hour. In light of World Blood Cancer Day which is commemorated every year on May 28, DKMS BMST Foundation India is calling on citizens to come forward and register as blood stem cell donors.

Every year, over 1 lakh people from India are diagnosed with blood cancer and disorders such as thalassemia and aplastic anemia. For many of these patients, a blood stem cell transplant is their only hope for survival. While conventional methods like chemotherapy and radiation therapy are available, a blood stem cell transplant is often crucial for patients who are at high risk of relapse or who do not respond well to conventional treatments.

Patrick Paul, CEO of DKMS BMST Foundation India, stresses the urgency of the situation: “In India, someone is diagnosed with blood cancer or a severe blood disorder every five minutes. Despite the global registry having over 41 million donors, India has only about 0.6 million registered. Thousands of patients are in dire need of matching stem cell donors to undergo life-saving transplants. We need to expand our donor database significantly to provide these patients a fighting chance.”

Dr. Nitin Agarwal, MD Transfusion Medicine, Head of Donor Request Management at DKMS BMST Foundation India, points out that a significant barrier to increasing donor numbers is the lack of public awareness. “Many people in India are unaware of what blood stem cell donation involves or have incorrect beliefs about the process. It’s crucial to understand that matching for stem cell transplants is based on Human Leukocyte Antigen (HLA) characteristics, not just blood type. Education is key to dispelling these misconceptions and encouraging more people to register.”

Public education campaigns are essential to address these issues. Misconceptions about the complexity and risks of the donation process deter many potential donors. Providing clear and accurate information can help people make informed decisions about registering as donors.

24-year-old Kunal, a blood stem cell donor, shared her experience: “In December 2022, I stumbled upon social media posts highlighting the importance of stem cell donation in the fight against blood cancer. I registered as a potential donor with DKMS-BMST by giving my cheek swab samples, but I thought it was a long shot that I would actually be called for a donation, considering how rare the opportunity was. Little did I know that this decision would lead me on a remarkable journey that would change my life and a total stranger’s life forever. Donating blood stem cells was one of the most fulfilling experiences of my life. The procedure was straightforward and caused minimal discomfort. I strongly encourage others to register as stem cell donors; it’s a safe process that can significantly impact someone’s life.”

Another donor, 23-year-old Loni Lipsa, echoed this sentiment: “I initially had misconceptions about the process involved, but I was pleasantly surprised by how simple and painless it was. One of the challenges was to get my parent’s permission to go ahead with the donation. Due to the lack of awareness, many people don’t know the importance of registering and if given a chance donating their stem cells. The thought of potentially saving someone’s life made every step worthwhile.”

This World Blood Cancer Day, we call upon people to take the first step towards becoming a lifesaver. To become a potential stem cell donor, the criteria is to be a healthy adult aged between 18 and 55.

You can register as a blood stem cell donor by ordering a home swab kit at www.dkms-bmst.org/register. Once you receive the swab kit, fill out a consent form and swab the inside of your cheeks to collect tissue cells and send your sample to the registry. Your buccal swab sample will be sent to a lab for HLA (Human Leukocyte Antigen) analysis and anonymously listed on an international donor search platform. Increasing awareness and encouraging more registrations for blood stem cell donors can provide hope to countless patients. Someone’s decision to register can make a life-saving difference to many lives.

By Dr Aditya Gupta, Director of Neurosurgery and Cyberknife, Artemis Hospital, Gurugram

Radiosurgery is an advanced non-invasive and high-precision medical procedure that uses a focused beam of radiation to treat tumors and other medical conditions. It is a very special form of radiation therapy that delivers high doses of radiation with precise accuracy to a concentrated area. Radiosurgery is used to treat a wide range of medical conditions, including benign and cancerous tumors of the brain, spine, lungs, liver, and prostate, as well as non-cancerous conditions such as trigeminal neuralgia.

One of the most advanced radiosurgery systems available today is the M6 CyberKnife. This cutting-edge system combines advanced imaging technology with a robotic arm that delivers high doses of radiation to tumors with sub-millimeter accuracy. The M6 CyberKnife can treat tumors anywhere in the body, including the brain, spine, lungs, liver, pancreas, and prostate. The system uses real-time imaging to track the position of the tumor and automatically adjusts the radiation beam to ensure that the tumor receives the correct lethal dose of radiation.

One of the key advantages of the M6 CyberKnife is its accuracy. The system can deliver high doses of radiation with extreme precision, which minimizes damage to surrounding healthy tissue. This precision also allows the M6 CyberKnife to treat tumors that may be difficult to access with traditional surgery, such as tumors located deep in the brain or spine. All this is accomplished without any pain, as this technology is frameless, and does not need a frame to be fixed onto the head.

Benign tumors – are non-cancerous growths that can occur in various parts of the body, including the brain, spine, and lungs. While these tumors are typically not life-threatening, they can cause significant discomfort and affect a person’s quality of life. Traditional surgery can be effective in removing benign tumors, but it can also be invasive and involve significant recovery time. CyberKnife offers a non-invasive alternative that delivers a high dose of radiation to the tumor with extreme accuracy, destroying the tumor cells while minimizing damage to surrounding healthy tissue. The compelling reason to avoid traditional surgery is also when the tumor is small, which is when radiosurgery is most effective.

AVMs – Arteriovenous Malformations are a rare condition that occurs when there is a malformation of the blood vessels in the brain or spinal cord. AVMs can cause a variety of symptoms, including headaches, seizures, and neurological deficits. Traditional surgery to remove an AVM can be risky and may involve significant recovery time. CyberKnife offers a safe and effective alternative, delivering a high dose of radiation to the AVM with extreme accuracy, leading to a gradual closure of the blood vessels.

Metastatic tumors – are tumors that have spread to other parts of the body from their original location. Metastasis is a common complication of many types of cancers, including breast, lung, and prostate cancer. Traditional treatments for metastatic tumors include surgery, chemotherapy, and radiation therapy. CyberKnife offers a targeted approach to treating metastatic tumors, delivering a high dose of radiation to the tumor with extreme precision while minimizing damage to surrounding healthy tissue.

Another advantage of the M6 CyberKnife is its non-invasive nature. Unlike traditional surgery, which requires incisions and can result in significant pain and recovery time, the M6 CyberKnife does not require any incisions or anesthesia. Patients can typically return to their normal activities immediately after treatment, within minutes.

The CyberKnife is a relatively new technology in India, and while there is limited data on its usage, it is steadily gaining popularity among medical practitioners and patients alike. Despite having high success rates, effectiveness, and 100% safety, this technology is underutilized in India as of now.

While more research is needed to fully understand the impact of CyberKnife on cancer treatment in India, the initial findings suggest that it is a promising option for patients who require precise and non-invasive treatment for various types of tumors and cancers.